Albemarle Corporation (ALB)

NYSE: ALB · Delayed Price · USD
-5.64 (-2.32%)
At close: May 25, 2022 4:00 PM
-1.18 (-0.50%)
After-hours:May 25, 2022 6:10 PM EDT

Company Description

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide.

It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets.

It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers.

The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives.

The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets.

Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Albemarle Corporation
Albemarle Logo
CountryUnited States
IPO DateFeb 17, 1994
CEOJerry Masters

Contact Details

4250 Congress St Ste 900
Charlotte, North Carolina 28209-4615
United States
Phone980 299 5700

Stock Details

Ticker SymbolALB
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code0000915913

Key Executives

Jerry Kent Masters Jr.Chairman, President and Chief Executive Officer
Scott A. TozierExecutive Vice President and Chief Financial Officer
Karen G. Narwold Esq.Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary
Eric W. NorrisPresident of Lithium Global Business Unit
Netha N. Johnson Jr.President of Bromine Specialties Global Business Unit
John Clarence Barichivich IIIVice President, Corporate Controller and Chief Accounting Officer
Patrick ThompsonChief Information Officer
Melissa H. AndersonSenior Vice President and Chief Human Resources Officer
Ahmad KhalifehManaging Director of Middle East Office
Raphael Goszcz CrawfordPresident of Catalysts Global Business Unit

Latest SEC Filings

May 13, 20228-KCurrent report
May 12, 2022424B5Prospectus [Rule 424(b)(5)]
May 11, 2022FWPFiling under Securities Act Rules 163/433 of free writing prospectuses
May 10, 2022424B3Prospectus [Rule 424(b)(3)]
May 4, 202210-QQuarterly report [Sections 13 or 15(d)]
May 4, 20228-KCurrent report
May 4, 20228-KCurrent report
Mar 22, 2022DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 22, 2022DEF 14AOther definitive proxy statements
Mar 9, 20228-KCurrent report
View All SEC Filings